Georg C. Terstappen

Georg C. Terstappen is the Executive Vice President of Drug Discovery at Cambrian Biopharma. He has 30 years of experience holding R&D leadership positions at Bayer, GW/GSK, and Abbott/AbbVie. Georg was also Co-Founder and CSO of Siena Biotech and CSO of OxStem. In addition, Georg has led EU R&D framework organizations as Vice-Chair of the Innovative Medicines Strategy group. He was an adjunct professor and visiting scientist at several universities, including the University of Oxford, for 10+ years & a leader of European-wide research programs funded by the EC. Georg has published 90 scientific articles and is an inventor/co-inventor of 15 patents. He received a PhD in natural sciences for research conducted at the Max-Planck-Institute in Cologne and the Federal Research Centre Juelich.